D.WESTERN THERAPEUTICS INST INCD.WESTERN THERAPEUTICS INST INCD.WESTERN THERAPEUTICS INST INC

D.WESTERN THERAPEUTICS INST INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪6.67 B‬JPY
−33JPY
‪−812.41 M‬JPY
‪428.36 M‬JPY
‪32.70 M‬
Beta (1Y)
−0.28
Employees (FY)
21
Change (1Y)
+1 +5.00%
Revenue / Employee (1Y)
‪20.40 M‬JPY
Net income / Employee (1Y)
‪−38.69 M‬JPY

About D.WESTERN THERAPEUTICS INST INC


Headquarters
Nagoya
Founded
2004
Website
ISIN
JP3548740004
FIGI
BBG000P8V2G8
D Western Therapeutics Institute, Inc is a Japan-based company engaged in the research and development of new pharmaceuticals. The Company generates revenue from licensing of its developed drugs to other companies. As of December 31, 2012, the Company’s drug pipeline included anti-thrombotic medicine K-134, therapeutic agent K-115 for glaucoma, and anticancer drug HMN-214. Its newly-developed products include new anti-thrombotic medicine and signal-transduction inhibitors, including therapeutic agent for high-blood pressure, protective agent for nerves, therapeutic agent for atherosclerosis, ophthalmologic drug and anticancer drug, among others. The Company is also developing new drug candidate compounds focusing on protein kinase inhibitors.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4576 is 201 JPY — it has increased by 23.31% in the past 24 hours. Watch D.WESTERN THERAPEUTICS INST INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange D.WESTERN THERAPEUTICS INST INC stocks are traded under the ticker 4576.
4576 stock has fallen by −7.37% compared to the previous week, the month change is a 111.58% rise, over the last year D.WESTERN THERAPEUTICS INST INC has showed a 39.58% increase.
4576 reached its all-time high on May 8, 2013 with the price of 3,755 JPY, and its all-time low was 59 JPY and was reached on Mar 15, 2011. View more price dynamics on 4576 chart.
See other stocks reaching their highest and lowest prices.
4576 stock is 24.61% volatile and has beta coefficient of −0.28. Track D.WESTERN THERAPEUTICS INST INC stock price on the chart and check out the list of the most volatile stocks — is D.WESTERN THERAPEUTICS INST INC there?
Today D.WESTERN THERAPEUTICS INST INC has the market capitalization of ‪6.67 B‬, it has decreased by −35.32% over the last week.
Yes, you can track D.WESTERN THERAPEUTICS INST INC financials in yearly and quarterly reports right on TradingView.
D.WESTERN THERAPEUTICS INST INC is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
4576 net income for the last quarter is ‪−206.50 M‬ JPY, while the quarter before that showed ‪−199.84 M‬ JPY of net income which accounts for −3.33% change. Track more D.WESTERN THERAPEUTICS INST INC financial stats to get the full picture.
No, 4576 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 21.00 employees. See our rating of the largest employees — is D.WESTERN THERAPEUTICS INST INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. D.WESTERN THERAPEUTICS INST INC EBITDA is ‪−938.77 M‬ JPY, and current EBITDA margin is −175.05%. See more stats in D.WESTERN THERAPEUTICS INST INC financial statements.
Like other stocks, 4576 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade D.WESTERN THERAPEUTICS INST INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So D.WESTERN THERAPEUTICS INST INC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating D.WESTERN THERAPEUTICS INST INC stock shows the buy signal. See more of D.WESTERN THERAPEUTICS INST INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.